Concepedia

Brandon Essink

BE

41

Publications

3.2K

Citations

26

H-Index

2013

Active since

Affiliations

Meridian Clinical Research(Current)

Moderna Therapeutics (United States)

Brigham and Women's Hospital

Baylor College of Medicine

Velocity Clinical Research (United States)

Brandon Essink is an author at Meridian Clinical Research specializing in medicine, vaccination, and vaccine development.

ORCID

Top concepts

Publications per year

2013–2025

41

Publications

41

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

Hana M. El Sahly, Lindsey R. Baden, Brandon Essink et al. · New England Journal of Medicine · 2021 · 647 citations · Full text

A Bivalent Omicron-Containing Booster Vaccine against Covid-19

Spyros Chalkias, Charles Harper, Keith Vrbicky et al. · New England Journal of Medicine · 2022 · 638 citations · Full text

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years

Brandon Essink, Charu Sabharwal, Kevin Cannon et al. · Clinical Infectious Diseases · 2021 · 154 citations · Full text

Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial

Spyros Chalkias, Frank Eder, Brandon Essink et al. · Nature Medicine · 2022 · 143 citations · Full text

The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials

Brandon Essink, Laurence Chu, William Seger et al. · The Lancet Infectious Diseases · 2023 · 129 citations

, , +8

Rows per page

1–5 of 41